Supriya Lifescience Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Supriya Lifescience Limited cash flow conversion efficiency. Based on the latest financial reports, Supriya Lifescience Limited (SUPRIYA) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs555.65 Million ≈ $6.01 Million USD) by net assets (Rs10.82 Billion ≈ $116.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Supriya Lifescience Limited (2018–2025)

Cash flow conversion efficiency of Supriya Lifescience Limited from 2018 to 2025. This chart illustrates how Supriya Lifescience Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Supriya Lifescience Limited share price for real-time trading data and today's change.

Supriya Lifescience Limited Cash Flow Conversion Ratio Explained

Supriya Lifescience Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Supriya Lifescience Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Supriya Lifescience Limited ranked by their cash flow conversion efficiency. Also see Supriya Lifescience Limited stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hunan Lead Power Dazhi Technology Inc Co SHE:300530	-0.195x
Amata Corporation Public Company Limited BK:AMATA-R	0.062x
Shenzhen Textile Holdings Co Ltd SHE:000045	-0.037x
HIMALAYA SHIPPING LTD DL1 F:J1X	0.153x
Chengdu Xinzhu Road&Bridge Machinery Co Ltd SHE:002480	0.090x
Sichuan Mingxing Electric Power Co Ltd SHG:600101	0.044x
Akva Group OL:AKVA	0.066x
Jiangsu Maixinlin Aviation Science & Technology Corp. A SHG:688685	0.244x

Annual Cash Flow Conversion Efficiency for Supriya Lifescience Limited (2018–2025)

The table below shows the annual cash flow conversion efficiency of Supriya Lifescience Limited from 2018 to 2025. Review Supriya Lifescience Limited free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs9.97 Billion ≈ $107.80 Million	Rs1.73 Billion ≈ $18.66 Million	0.173x	+24.58%
2024-03-31	Rs8.15 Billion ≈ $88.18 Million	Rs1.13 Billion ≈ $12.25 Million	0.139x	+46.86%
2023-03-31	Rs6.99 Billion ≈ $75.64 Million	Rs661.87 Million ≈ $7.16 Million	0.095x	+19.38%
2022-03-31	Rs6.16 Billion ≈ $66.58 Million	Rs488.01 Million ≈ $5.28 Million	0.079x	-73.33%
2021-03-31	Rs2.69 Billion ≈ $29.08 Million	Rs799.30 Million ≈ $8.64 Million	0.297x	-61.80%
2020-03-31	Rs1.49 Billion ≈ $16.13 Million	Rs1.16 Billion ≈ $12.55 Million	0.778x	+49.91%
2019-03-31	Rs937.91 Million ≈ $10.14 Million	Rs486.72 Million ≈ $5.26 Million	0.519x	+62.52%
2018-03-31	Rs546.57 Million ≈ $5.91 Million	Rs174.52 Million ≈ $1.89 Million	0.319x	--

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$605.62 Million

Rs56.00 Billion INR

Market Cap Rank

#10930 Global

#552 in India

Share Price

Rs695.80

Change (1 day)

-19.99%

52-Week Range

Rs553.35 - Rs1052.50

All Time High

Rs1052.50